Plagiarism Policy

The Journal of Cancer and Translational Oncology maintains a strict anti-plagiarism policy to ensure the originality, integrity, and scientific credibility of all published research in oncology and translational medicine.

All submitted manuscripts are screened using reliable plagiarism detection tools before they are sent for peer review. This ensures that the work is original and that all sources, data, and prior research are properly acknowledged.

Plagiarism in any form is considered a serious ethical violation and is not acceptable. This includes, but is not limited to:

• Direct copying of text, figures, tables, or data without proper citation

• Paraphrasing substantial content from other sources without acknowledgment

• Self-plagiarism or duplicate publication of the author’s own work without disclosure

• Submission of work that overlaps significantly with previously published studies

• Improper reuse of clinical data, images, or results without attribution

If plagiarism is detected at any stage of the editorial or publication process, the manuscript may be:

• Rejected before peer review

• Returned to authors for correction and resubmission (in minor cases)

• Retracted or withdrawn if identified after publication

Authors are fully responsible for ensuring the originality of their work and for properly citing all references, datasets, and prior publications used in their research.

The journal follows internationally recognized publication ethics guidelines, including COPE standards, to handle all plagiarism-related cases in a fair, consistent, and transparent manner.

Through this policy, the Journal of Cancer and Translational Oncology upholds the highest standards of academic integrity and ensures trust in scientific publishing.